Morganti, Alessio Giuseppe
 Distribuzione geografica
Continente #
EU - Europa 7.068
NA - Nord America 6.366
AS - Asia 1.859
AF - Africa 73
SA - Sud America 19
Continente sconosciuto - Info sul continente non disponibili 18
OC - Oceania 13
Totale 15.416
Nazione #
US - Stati Uniti d'America 6.270
DE - Germania 3.110
SE - Svezia 1.264
CN - Cina 903
UA - Ucraina 627
IT - Italia 550
SG - Singapore 348
IE - Irlanda 332
FR - Francia 285
GB - Regno Unito 244
ID - Indonesia 214
FI - Finlandia 174
IN - India 157
PL - Polonia 148
RU - Federazione Russa 127
TR - Turchia 103
CA - Canada 90
CI - Costa d'Avorio 65
BE - Belgio 62
CZ - Repubblica Ceca 52
JP - Giappone 37
IR - Iran 32
NL - Olanda 26
HK - Hong Kong 24
VN - Vietnam 16
EU - Europa 12
AU - Australia 11
RO - Romania 11
ES - Italia 10
CH - Svizzera 7
CL - Cile 7
EG - Egitto 6
PT - Portogallo 6
RS - Serbia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AT - Austria 4
GR - Grecia 4
IL - Israele 4
AR - Argentina 3
BR - Brasile 3
DK - Danimarca 3
HU - Ungheria 3
LK - Sri Lanka 3
MX - Messico 3
MY - Malesia 3
PE - Perù 3
A1 - Anonimo 2
EC - Ecuador 2
HR - Croazia 2
JO - Giordania 2
KZ - Kazakistan 2
LT - Lituania 2
LU - Lussemburgo 2
MK - Macedonia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
AG - Antigua e Barbuda 1
AL - Albania 1
BD - Bangladesh 1
BZ - Belize 1
CM - Camerun 1
EE - Estonia 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
MD - Moldavia 1
NP - Nepal 1
PA - Panama 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TW - Taiwan 1
VE - Venezuela 1
Totale 15.416
Città #
Chandler 1.538
Ashburn 494
Jacksonville 385
Dublin 330
San Mateo 310
Nanjing 230
Singapore 229
Dearborn 216
Ann Arbor 215
Jakarta 213
Wilmington 192
Nürnberg 183
Woodbridge 153
New York 149
Boston 147
Warsaw 145
Milan 129
Bremen 127
Marseille 118
Lawrence 103
Izmir 101
Beijing 95
Nanchang 92
Cattolica 89
Princeton 85
Moscow 84
Houston 80
Fairfield 77
Redwood City 71
Abidjan 65
Brussels 62
Leawood 61
Rome 61
Seattle 60
Helsinki 54
Los Angeles 49
Munich 46
Zhengzhou 44
North York 42
Boardman 41
University Park 39
Kunming 37
Toronto 37
Hebei 36
Shenyang 36
Jiaxing 35
Augusta 34
Fremont 32
Changsha 29
Tianjin 29
Phoenixville 28
Cambridge 27
Mountain View 26
Norwalk 26
Detroit 24
Lancaster 24
Auburn Hills 23
Brno 21
Hangzhou 21
Pune 21
Washington 19
Falls Church 18
Guangzhou 17
Redmond 16
Shanghai 16
Amsterdam 15
Hanoi 15
Monmouth Junction 15
Edinburgh 13
Lanzhou 13
Enterprise 12
Hong Kong 12
Andover 11
Hefei 11
Jinan 11
Ardabil 9
Chicago 9
Indiana 9
San Francisco 9
Dresden 8
Sacramento 8
Bari 7
Central District 7
Costa Mesa 7
Ningbo 7
Sergii 7
Simi Valley 7
Tokyo 7
Wuhan 7
Arezzo 6
Berlin 6
Kish 6
Landshut 6
London 6
Mumbai 6
Phoenix 6
Bologna 5
Chengdu 5
Saint Paul 5
Turin 5
Totale 7.934
Nome #
Clinical outcome of recurrent locally advanced cervical cancer (lacc) submitted to primary multimodality therapies 794
Results of a phase II study of Short-course Accelerated Radiation Therapy (SHARON) for multiple brain metastases 253
A National project for in vivo dosimetry procedures in radiotherapy: First results 246
Low-dose fractionated radiotherapy and concomitant chemotherapy in glioblastoma multiforme with poor prognosis: a feasibility study 236
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 171
A National project for in vivo dosimetry procedures in radiotherapy: First results 166
Mammography before post-operative radiotherapy in conservatively managed breast cancer patients: is it useful? 162
Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studies 160
Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery 159
Chemoradiation and brachytherapy in biliary tract carcinoma - Long-term results 145
Volumetric modulated arc therapy with simultaneous integrated boost for locally advanced rectal cancer 142
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 139
Long-term Analysis of Gemcitabine-based Chemoradiation after Surgical Resection for Pancreatic Adenocarcinoma 136
Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma 136
Radioprotective effect of moderate wine consumption in patients with breast carcinoma. 135
Planning comparison between standard and conformal 3D techniques in post-operative radiotherapy of gastric cancer: a systematic review 134
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 133
Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report 132
Short-Course Accelerated Radiotherapy in Palliative Treatment of Advanced Pelvic Malignancies: A Phase I Study 131
Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study. 127
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 127
Intensity-modulated radiotherapy with simultaneous integrated boost to dominant intraprostatic lesion: preliminary report on toxicity 126
Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients. 126
A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer. 125
Multiple tumor marker elevation in androgen ablation-refractory prostate cancer with long-term response to metronomic chemotherapy: a case report 125
Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1) 125
Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: feasibility and clinical results 125
Postoperative intensity modulated radiation therapy in high risk prostate cancer: A dosimetric comparison. 124
Long-term analysis of gemcitabine-based chemoradiation after surgical resection for pancreatic adenocarcinoma 124
Clinical target volume delineation including elective nodal irradiation in preoperative and definitive radiotherapy of pancreatic cancer 123
Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2) 121
Quality of life and toxicity of stereotactic radiotherapy in pancreatic tumors: a case series 120
Endocavitary in vivo dosimetry for IMRT treatments of gynecologic tumors 120
External beam radiotherapy plus 24 hours continuous infusion of gemcitabine in unresectable pancreatic carcinoma: long term result of a phase II study 118
Early radiation-induced mucosal changes evaluated by proctoscopy: Predictive role of dosimetric parameters 117
Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison 114
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 112
A phase I study of short-course accelerated whole brain radiation therapy for multiple brain metastases 111
Eccrine Syringofibroadenoma radiation treatment of an unusual presentation 110
Clinical management of gastroesophageal junction tumors: past and recent evidences for the role of radiotherapy in the multidisciplinary approach 110
A complete pathological response to treatment in a young patient with locally advanced minimal deviation adenocarcinoma of the uterine cervix undergoing chemoradiation followed by radical surgery 109
Incidence and management of noncancer pain in cancer patients referred to a radiotherapy center 109
Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy 108
Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study 107
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: preliminary results of a phase II trial 107
In Vivo Portal Dosimetry by an Ionization Chamber 106
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 106
FOLFIRI-bevacizumab and concurrent low-dose radiotherapy in metastatic colorectal cancer: preliminary results of a phase I-II study 106
Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer: A Phase II Study 106
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 104
Inter-observer variability of clinical target volume delineation in radiotherapy treatment of pancreatic cancer: a multi-institutional contouring experience 104
Radiotherapy and concurrent metronomic chemotherapy in hormone-refractory prostate carcinoma: a Phase I study 102
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study 101
Intraoperative radiation therapy in resected pancreatic carcinoma: long-term analysis. 100
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 100
Patterns of radiotherapy practice for pancreatic cancer: Results of the Gastrointestinal Radiation Oncology Study Group multi-institutional survey 100
Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (≥75 years) Patients 100
Adjuvant chemoradiotherapy in gastric cancer: a pooled analysis of the AIRO gastrointestinal group experience 100
Forward-planned intensity modulated radiation therapy using a cobalt source: A dosimetric study in breast cancer 97
Short-course radiotherapy in elderly patients with early stage non-melanoma skin cancer: a phase II study 97
An in-vivo dosimetry procedure for Elekta step and shoot IMRT 96
[Radiotherapy in men with prostate cancer: indications, evolutions and integrated approaches] 96
Multi-institutional pooled analysis on adjuvant chemoradiation in pancreatic cancer 95
Concomitant boost dose escalation plus large-field preoperative chemoradiation in locally advanced carcinoma of the uterine cervix: results of a phase I study (LARA-CC-1). 93
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase ii study (ester-1). 93
Phase I-II studies on accelerated IMRT in breast carcinoma: Technical comparison and acute toxicity in 332 patients. 93
Extracranial radiosurgery with volumetric modulated arc therapy: Feasibility evaluation of a phase I trial 92
A phase I dose-escalation study (iside-bt-1) of accelerated imrt with temozolomide in patients with glioblastoma. 91
Stereotactic radiotherapy in recurrent gynecological cancer: a case series 91
Assessing the feasibility of volumetric-modulated arc therapy using simultaneous integrated boost (SIB-VMAT): An analysis for complex head-neck, high-risk prostate and rectal cancer cases 91
Initial clinical experience with Epid-based in-vivo dosimetry for VMAT treatments of head-and-neck tumors 90
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 89
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 88
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 88
Real time transit dosimetry for the breath-hold radiotherapy technique experience 87
Role of comorbidities in locally advanced cervical cancer patients administered preoperative chemoradiation: Impact on outcome and treatment-related complications. 86
Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1) 85
Underuse of brachytherapy for the treatment of dysphagia owing to esophageal cancer. An Italian survey 84
RANDOMIZED, MULTICENTER, PHASE IIB STUDY OF PREOPERATIVE CHEMORADIOTHERAPY IN T3 MID-DISTAL RECTAL CANCER: RALTITREXED + OXALIPLATIN + RADIOTHERAPY VERSUS CISPLATIN + 5-FLUOROURACIL + RADIOTHERAPY. 83
Radioprotective effect of calcium channel blockers against late rectal bleeding in prostate cancer 83
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase II study (ESTER-1). 82
Complexity index (COMIX) and not type of treatment predicts undetected errors in radiotherapy planning and delivery. 82
Active Breathing Coordinator in adjuvant three-dimensional conformal radiotherapy of early stage breast cancer: a feasibility study. 82
Synchronous male carcinoma of the breast, exocrine pancreas, and prostate 82
Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in Patients With Brain Oligometastases: A Phase 1 Study (ISIDE-BM-1) 82
Neoadjuvant Accelerated Concomitant Boost Radiotherapy and Multidrug Chemotherapy in Locally Advanced Rectal Cancer: A Dose-Escalation Study 82
Low-dose radiotherapy and concurrent FOLFIRI-bevacizumab: A Phase II study 81
Preoperative chemoradiation with raltitrexed (Tomudex) in T2/N+ and T3/N+ rectal cancers: a phase I study. 80
Palliative two-dimensional radiotherapy of pancreatic carcinoma: a feasibility study. 80
Successful Treatment of a Young Patient with Locally Advanced Clear Cell Adenocarcinoma of the Uterine Cervix Undergoing Chemoradiation Followed by Radical Surgery 79
Intensity-modulated extended-field chemoradiation plus simultaneous integrated boost in the pre-operative treatment of locally advanced cervical cancer: a dose-escalation study 79
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: Preliminary results of a phase II trial 78
Palliative short-course radiation therapy in rectal cancer: A phase 2 study 78
Optimal beam margins in linac-based VMAT stereotactic ablative body radiotherapy: A Pareto front analysis for liver metastases 75
A Large, Multicenter, Retrospective Study on Efficacy and Safety Of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups 75
Clinical outcome of recurrent locally advanced cervical cancer (LACC) submitted to primary multimodality therapies 74
Volumetric modulated arc therapy (VMAT) and simultaneous integrated boost in head-and-neck cancer: Is there a place for critical swallowing structures dose sparing? 74
18 F-FDG Pet-Guided External Beam Radiotherapy in Iodine-Refractory Differentiated Thyroid Cancer: A Pilot Study 74
Intra-operative radiotherapy (IORT) in pancreatic cancer: Joint analysis of the ISIORT-Europe experience. 72
Concurrent Chemoradiation with Concomitant Boost in Locally Advanced Rectal Cancer: A Phase II Study 72
Totale 11.666
Categoria #
all - tutte 61.772
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.772


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.886 0 0 106 99 217 223 298 136 216 163 265 163
2020/20211.452 81 171 30 156 204 64 140 42 167 107 228 62
2021/20221.822 188 130 32 108 116 69 28 257 73 125 332 364
2022/20234.181 569 590 312 678 273 475 230 342 464 37 160 51
2023/20241.806 66 532 83 149 44 231 103 137 18 49 235 159
2024/2025450 107 98 245 0 0 0 0 0 0 0 0 0
Totale 16.090